PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
A new study published in the Journal of Psychopharmacology is the first to characterize the psychological impacts of psilocybin among people with bipolar disorder.
The findings indicate that many people with bipolar disorder who consume psilocybin, the primary psychoactive component of psychedelic “magic mushrooms,” believe that the experience is helpful. However, many also report adverse outcomes, such as manic symptoms.
Read moreThere is still no definitive evidence that microdosing with psychedelics is either effective or safe. Keep reading to read the potential benefits and risks.
Read moreIs it all hype or is there genuine hope for therapeutic application of microdosing?
There’s certainly plenty of ‘conflicting’ information or results available from studies of different methodologies. Here, we begin with an overview of what microdosing is, who does it, and for what purposes. We then review available evidence and summarize benefits and risks of microdosing. Finally, we get more practical and discuss microdosing regimens, measurement of accurate dosing, and ‘set and setting’ consideration to microdosing.
from Ben Malcolm, Spirit Pharmacist
This article breaks down the current trend of microdosing, and the lack of solid research.
Read moreThis study looks at four scientific articles on microdosing. Three of these indicate potential benefits from microdosing.
Read moreThe jury is out on the effectiveness of microdosing psychedelics, experts say.
But definitely don't do it at work.
Read moreNew research shows that benefits of microdosing may be comparable to other wellness activities such as yoga.
Read moreHere’s a look at the benefits and challenges of microdosing or macrodosing.
Read morePeople who microdose psychedelic drugs report that the benefits greatly outweigh the drawbacks.
Read moreNew research shows that microdosing LSD elevates mood and cognition.
Read more